D. C. Montefiori

876 total citations
14 papers, 508 citations indexed

About

D. C. Montefiori is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, D. C. Montefiori has authored 14 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in D. C. Montefiori's work include HIV Research and Treatment (10 papers), T-cell and Retrovirus Studies (3 papers) and HIV/AIDS drug development and treatment (3 papers). D. C. Montefiori is often cited by papers focused on HIV Research and Treatment (10 papers), T-cell and Retrovirus Studies (3 papers) and HIV/AIDS drug development and treatment (3 papers). D. C. Montefiori collaborates with scholars based in United States. D. C. Montefiori's co-authors include W M Mitchell, William E. Robinson, William M. Mitchell, A. M. Prince, J. W. Eichberg, H. J. Alter, G R Dreesman, Shari L. Lydy, Barney S. Graham and R. Paul Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Microbiology.

In The Last Decade

D. C. Montefiori

7 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. C. Montefiori United States	6	344	225	210	153	89	14	508
S Conley United States	8	463 1.3×	244 1.1×	199 0.9×	124 0.8×	120 1.3×	9	553
Sydney Stanley United States	9	354 1.0×	212 0.9×	312 1.5×	157 1.0×	120 1.3×	14	602
B. Davison‐Fairburn United States	7	462 1.3×	217 1.0×	234 1.1×	235 1.5×	84 0.9×	9	573
Livia Berlinger Switzerland	7	282 0.8×	151 0.7×	163 0.8×	92 0.6×	76 0.9×	11	403
Jin Tao Zhou United States	7	668 1.9×	317 1.4×	453 2.2×	190 1.2×	92 1.0×	7	792
Ron Plishka United States	9	629 1.8×	293 1.3×	343 1.6×	235 1.5×	152 1.7×	10	711
Susumu Ohkawa United States	9	402 1.2×	186 0.8×	257 1.2×	237 1.5×	85 1.0×	17	550
Jaap Goudsmit Netherlands	10	536 1.6×	361 1.6×	147 0.7×	111 0.7×	124 1.4×	13	604
Takeo Kuwata Japan	20	803 2.3×	371 1.6×	423 2.0×	327 2.1×	115 1.3×	80	941
Tonya Swanson United States	3	430 1.3×	184 0.8×	425 2.0×	288 1.9×	154 1.7×	6	766

Countries citing papers authored by D. C. Montefiori

Since Specialization

Citations

This map shows the geographic impact of D. C. Montefiori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. C. Montefiori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. C. Montefiori more than expected).

Fields of papers citing papers by D. C. Montefiori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. C. Montefiori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. C. Montefiori. The network helps show where D. C. Montefiori may publish in the future.

Co-authorship network of co-authors of D. C. Montefiori

This figure shows the co-authorship network connecting the top 25 collaborators of D. C. Montefiori. A scholar is included among the top collaborators of D. C. Montefiori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. C. Montefiori. D. C. Montefiori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Routhu, Nanda Kishore, Venkata S. Bollimpelli, Chris Ibegbu, et al.. (2021). Compromised SARS-CoV-2 neutralizing antibody response in cord blood versus mothers. 29(1). 223–223. 1 indexed citations

Salazar-Gonzalez, Jesus F., et al.. (2020). Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing. UNC Libraries.

Montefiori, D. C., et al.. (2020). Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine. UNC Libraries.

Tomaras, Georgia D., et al.. (2020). The Development of CD4 Binding Site Antibodies during HIV-1 Infection. UNC Libraries.

Montefiori, D. C., et al.. (2020). Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles. UNC Libraries.

Montefiori, D. C., et al.. (2020). The Genetic Bottleneck in Vertical Transmission of Subtype C HIV-1 Is Not Driven by Selection of Especially Neutralization-Resistant Virus from the Maternal Viral Population. UNC Libraries.

Montefiori, D. C., et al.. (2020). Regional Clustering of Shared Neutralization Determinants on Primary Isolates of Clade C Human Immunodeficiency Virus Type 1 from South Africa. UNC Libraries.

Scarlatti, Gabriella, José Alcamı́, Vera Bongertz, et al.. (2009). Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group. Lund University Publications (Lund University).

Robinson, H L, D. C. Montefiori, R. Paul Johnson, et al.. (2000). DNA priming and recombinant pox virus boosters for an AIDS vaccine.. PubMed. 104. 93–100. 10 indexed citations

10.

Graham, Barney S., et al.. (1990). Antifusion activity in sera from persons infected with human immunodeficiency virus type 1. Journal of Clinical Microbiology. 28(12). 2608–2611. 6 indexed citations

11.

Robinson, William E., D. C. Montefiori, W M Mitchell, et al.. (1989). Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.. Proceedings of the National Academy of Sciences. 86(12). 4710–4714. 98 indexed citations

12.

Robinson, William E., D. C. Montefiori, & W M Mitchell. (1988). ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION. The Lancet. 331(8589). 790–794. 293 indexed citations

13.

Montefiori, D. C. & William M. Mitchell. (1987). Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.. Proceedings of the National Academy of Sciences. 84(9). 2985–2989. 66 indexed citations

14.

Mitchell, W M, et al.. (1987). MISMATCHED DOUBLE-STRANDED RNA (AMPLIGEN) REDUCES CONCENTRATION OF ZIDOVUDINE (AZIDOTHYMIDINE) REQUIRED FOR IN-VITRO INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS. The Lancet. 329(8538). 890–892. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact